Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells

Nephrology Dialysis Transplantation

Volumn 28, Issue 4, 2013, Pages 869-878

  Louvet, Loïc ^a,b   Büchel, Janine ^c   Steppan, Sonja ^c   Passlick Deetjen, Jutta ^d   Massy, Ziad A ^a,b,e  

^a INSERM   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

^c FRESENIUS MEDICAL CARE   (Germany)

^d HEINRICH HEINE UNIVERSITY   (Germany)

^e AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

chronic kidney disease; human aortic vascular smooth muscle cells; magnesium; phosphate

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; MAGNESIUM; MAGNESIUM CHLORIDE; MATRIX PROTEIN; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; OSTEOPONTIN; PHOSPHATE; TRANSIENT RECEPTOR POTENTIAL CHANNEL M7;

ARTICLE; BLOOD VESSEL CALCIFICATION; CELL DIFFERENTIATION; CELL LEVEL; CELL VIABILITY; CELLULAR SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MARKER; DRUG ACTIVITY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; INCUBATION TIME; MINERALIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; VASCULAR SMOOTH MUSCLE;

AORTA; CELL SURVIVAL; CELLS, CULTURED; HUMANS; MAGNESIUM; MINERALS; MUSCLE, SMOOTH, VASCULAR; PHOSPHATES; TRPM CATION CHANNELS; VASCULAR CALCIFICATION;

EID: 84875999448     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs520     Document Type: Article

References (50)

1. Takasu J, Budoff MJ, Katz R et al. Relationship between common carotid intima-media thickness and thoracic aortic calcification: the multi-ethnic study of atherosclerosis. Atherosclerosis 2010; 2: 142-146
2. Ishiyama M, Suzuki E, Katsuda J et al. Associations of coronary artery calcification and carotid intima-media thickness with plasma concentrations of vascular calcification inhibitors in type 2 diabetic patients. Diabetes Res Clin Pract 2009; 2: 189-196
3. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 2: 394-401 (Pubitemid 26075849)
4. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 2: 239-245 (Pubitemid 28511522)
5. London GM, Guérin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 2: 1731-1740 (Pubitemid 37098542)
6. Noordzij M, Cranenburg EM, Engelsman LF et al.; NECOSAD Study Group. Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 2011; 2: 1662-1669
7. Moe SM, Chen NX. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 2004; 2: 560-567 (Pubitemid 39274370)
8. Giachelli CM. Vascular calcification: in vitro evidence for the role of inorganic phosphate. J Am Soc Nephrol 2003; 14 (9 Suppl 4): S300-S304 (Pubitemid 37052394)
9. Shanahan CM, Crouthamel MH, Kapustin A et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 2011; 2: 697-711
10. Tyson KL, Reynolds JL, McNair R et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003; 2: 489-494 (Pubitemid 36337227)
11. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005; 2: 105-114 (Pubitemid 41033466)
12. Ishimura E, Okuno S, Kitatani K et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol 2007; 2: 222-227 (Pubitemid 47527442)
13. Turgut F, Kanbay M, Metin MR et al. Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis. Int Urol Nephrol 2008; 2: 1075-1082
14. Massy ZA, Drüeke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J 2012; 5 (Suppl 1): i52-i61
15. Nakatani S, Mano H, Ryanghyok IM et al. Excess magnesium inhibits excess calcium-induced matrix-mineralization and production of matrix gla protein (MGP) by ATDC5 cells. Biochem Biophys Res Commun 2006; 2: 1157-1162 (Pubitemid 44233534)
16. Montezano AC, Zimmerman D, Yusuf H et al. Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium. Hypertension 2010; 2: 453-462
17. Salem S, Bruck H, Bahlmann FH et al. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification. Am J Nephrol 2012; 2: 31-39
18. Kircelli F, Peter ME, Sevinc Ok E et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant 2012; 2: 514-521
19. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 1971; 2: 172-186
20. Skalli O, Pelte MF, Peclet MC et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. J Histochem Cytochem 1989; 2: 315-321 (Pubitemid 19063429)
21. Gitelman HJ. An improved automated procedure for the determination of calcium in biological specimens. Anal Biochem 1967; 2: 521
22. Villa-Bellosta R, Millan A, Sorribas V. Role of calcium-phosphate deposition in vascular smooth muscle cell calcification. Am J Physiol Cell Physiol 2011; 2: C210-C220
23. Ivanovski O, Nikolov IG, Joki N et al. The calcimimetic R-568 retards uremia-enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE?/?) mice. Atherosclerosis 2009; 2: 55-62
24. Hamaguchi Y, Matsubara T, Amano T et al. Na+-independent Mg2+ transport sensitive to 2-aminoethoxydiphenyl borate (2-APB) in vascular smooth muscle cells: involvement of TRPMlike channels. J Cell Mol Med 2008; 2: 962-974 (Pubitemid 351718074)
25. Sage AP, Lu J, Tintut Y et al. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int 2011; 2: 414-422
26. Ennever J, Vogel JJ. Magnesium inhibition of apatite nucleation by proteolipid. J Dent Res 1981; 2: 838-841
27. Boskey AL, Posner AS. Effect of magnesium on lipid-induced calcification: an in vitro model for bone mineralization. Calcif Tissue Int 1980; 2: 139-143 (Pubitemid 11234463)
28. Giachelli CM, Speer MY, Li X et al. Regulation of vascular calcification: roles of phosphate and osteopontin. Circ Res 2005; 2: 717-722 (Pubitemid 40559510)
29. Ducy P, Desbois C, Boyce B et al. Increased bone formation in osteocalcin deficient mice. Nature 1996; 2: 448-452 (Pubitemid 26264860)
30. Murshed M, Schinke T, McKee MD et al. Extracellular matrix mineralization is regulated locally; different roles of two gla-containing proteins. J Cell Biol 2004; 2: 625-630 (Pubitemid 38765764)
31. Price PA, Thomas GR, Pardini AW et al. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J Biol Chem 2002; 2: 3926-3934 (Pubitemid 34968645)
32. Roy ME, Nishimoto SK. Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 2002; 2: 296-302 (Pubitemid 34814964)
33. Price PA, Faus SA, Williamson MK. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler Thromb Vasc Biol 2000; 2: 317-327 (Pubitemid 30086086)
34. Shanahan CM, Cary NR, Salisbury JR et al. Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999; 2: 2168-2176
35. Proudfoot D, Skepper JN, Shanahan CM et al. Calcification of human vascular cells in vitro is correlated with high levels of matrix Gla protein and low levels of osteopontin expression. Arterioscler Thromb Vasc Biol 1998; 2: 379-388 (Pubitemid 28125632)
36. Spronk HM, Soute BA, Schurgers LJ et al. Matrix Gla protein accumulates at the border of regions of calcification and normal tissue in the media of the arterial vessel wall. Biochem Biophys Res Commun 2001; 2: 485-490 (Pubitemid 33141080)
37. Schurgers LJ, Spronk HM, Skepper JN et al. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007; 2: 2503-2511 (Pubitemid 350154362)
38. Lomashvili KA, Wang X, Wallin R et al. Matrix Gla protein metabolism in vascular smooth muscle and role in uremic vascular calcification. J Biol Chem 2011; 2: 28715-28722
39. Schurgers LJ, Barreto DV, Barreto FC et al. The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease: a preliminary report. Clin J Am Soc Nephrol 2010; 2: 568-575
40. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000; 2: 20197-20203 (Pubitemid 30441631)
41. Chen Y, Bal BS, Gorski JP. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem 1992; 2: 24871-24878
42. Speer MY, Chien YC, Quan M et al. Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro. Cardiovasc Res 2005; 2: 324-333 (Pubitemid 40471047)
43. Proudfoot D, Skepper JN, Hegyi L et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000; 2: 1055-1062
44. Abed E, Martineau C, Moreau R. Role of melastatin transient receptor potential 7 channels in the osteoblastic differentiation of murine MC3T3 cells. Calcif Tissue Int 2011; 2: 246-253
45. Abed E, Moreau R. Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor. Am J Physiol Cell Physiol 2009; 2: C360-C368
46. Callera GE, He Y, Yogi A et al. Regulation of the novel Mg2+ transporter transient receptor potential melastatin 7 (TRPM7) cation channel by bradykinin in vascular smooth muscle cells. J Hypertens 2009; 2: 155-166
47. Hutchison AJ, Wilkie M. Use of magnesium as a drug in chronic kidney disease. Clin Kidney J 2012; 5 (Suppl 1): i62-i70
48. Spiegel DM, Farmer B, Smits G et al. Magnesium carbonate is an effective phosphate binder for chronic hemodialysis patients: a pilot study. J Ren Nutr 2007; 2: 416-422 (Pubitemid 350001351)
49. de Francisco AL, Leidig M, Covic AC et al. Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability. Nephrol Dial Transplant 2010; 2: 3707-3717
50. Kanbay M, Yilmaz MI, Apetrii M et al. Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012; 2: 228-237